An FDA perspective on the use of 3D printing in medical applications (Plastics Today)
A dedicated follower of 3D printing in the medical space, Steven K. Pollack, PhD, Director of the Office of Science & Engineering Labs at FDA, will participate in a panel discussion on 3D printing at next month's MD&M West exhibition and conference. In addition to the regulatory issues surrounding 3D printing, industry experts, researchers, and academics will discuss material developments, functional prototyping, bioprinting, and IP concerns during the daylong conference. In advance of the session, wh...